Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4210743
Max Phase: Preclinical
Molecular Formula: C42H58N4O9S
Molecular Weight: 795.01
Molecule Type: Small molecule
Associated Items:
ID: ALA4210743
Max Phase: Preclinical
Molecular Formula: C42H58N4O9S
Molecular Weight: 795.01
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1cc2ccc3cc2cc1CCCC(C)(C)CCOC(=O)N[C@@H](C(C)(C)C)C(=O)N1C[C@@]3(OC)C[C@H]1C(=O)N[C@]1(C(=O)NS(=O)(=O)C2CC2)C[C@H]1C1CC1
Standard InChI: InChI=1S/C42H58N4O9S/c1-39(2,3)34-36(48)46-24-41(54-7,23-32(46)35(47)44-42(22-31(42)25-10-11-25)37(49)45-56(51,52)30-14-15-30)29-13-12-26-21-33(53-6)27(19-28(26)20-29)9-8-16-40(4,5)17-18-55-38(50)43-34/h12-13,19-21,25,30-32,34H,8-11,14-18,22-24H2,1-7H3,(H,43,50)(H,44,47)(H,45,49)/t31-,32-,34+,41-,42+/m0/s1
Standard InChI Key: XWMLCUOICPXZQV-ZHJKUISPSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 795.01 | Molecular Weight (Monoisotopic): 794.3925 | AlogP: 5.08 | #Rotatable Bonds: 8 |
Polar Surface Area: 169.44 | Molecular Species: ACID | HBA: 9 | HBD: 3 |
#RO5 Violations: 2 | HBA (Lipinski): 13 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.77 | CX Basic pKa: | CX LogP: 4.91 | CX LogD: 3.97 |
Aromatic Rings: 2 | Heavy Atoms: 56 | QED Weighted: 0.33 | Np Likeness Score: 0.35 |
1. Bowsher M, Hiebert S, Li R, Wang AX, Friborg J, Yu F, Hernandez D, Wang YK, Klei H, Rajamani R, Mosure K, Knipe JO, Meanwell NA, McPhee F, Scola PM.. (2018) The discovery and optimization of naphthalene-linked P2-P4 Macrocycles as inhibitors of HCV NS3 protease., 28 (1): [PMID:29162454] [10.1016/j.bmcl.2017.11.005] |
Source(1):